#personalized-medicine

All articles tagged with "personalized-medicine"

Northeastern University researchers developed a custom video game to test working memory in adults over 50 with HIV.
The study involved 50 participants from across the US, playing a game where they recall sequences of gems.
Results showed differences in game effectiveness between HIV-positive and HIV-negative participants.
The research emphasizes the need for personalized cognitive interventions rather than one-size-fits-all approaches.

DT Editorial Team·Aug 17, 2026·via medicalxpress.com

AI-driven digital organisms are virtual replicas of living systems that learn and adapt.
They could transform drug discovery by simulating drug interactions before human trials.
Personalized digital twins could guide treatment decisions for individual patients.
Technical challenges include data integration, computational power, and privacy concerns.

DT Editorial Team·Aug 15, 2026·via nature.com

Study analyzed tumor samples from 513 postmenopausal women with ER+/HER2- breast cancer from the STO-3 trial.
Patients with low immune cell abundance in the tumor microenvironment had greater long-term benefit from tamoxifen.
Blood vessel and connective tissue cell levels also influenced treatment outcomes.
Findings may help personalize hormone therapy decisions.

DT Editorial Team·Aug 7, 2026·via medicalxpress.com

Researchers studied 73 people with mild cognitive impairment or early dementia.
Treatment plans targeted personal risk factors such as deficiencies, infections, hormones, and exposures.
The study reported improvements in memory and day-to-day functioning.

DT Editorial Team·Apr 24, 2026·via newscientist.com

OpenAI executives amplified a story about an AI-assisted treatment for a dog with cancer.
The report says there is no evidence the custom vaccine actually worked.
Critics argue an approved PD-1 inhibitor is the more likely explanation for improvement.

DT Editorial Team·Mar 30, 2026·via the-decoder.com

Twin Health creates AI-powered digital replicas of patients' metabolisms using data from four wearable sensors
The system processes 3,000 daily data points to generate personalized nutrition and lifestyle recommendations
Clinical trials showed 89% of participants achieved target blood sugar levels while reducing medications
The company recently raised $53 million to expand its digital twin technology platform
The approach could help patients reduce dependence on costly GLP-1 drugs like Ozempic

DT Editorial Team·Feb 17, 2026·6 min read·via wired.com